Giovanna Zanoni

COVID-19 Vaccination in Pregnancy, Paediatrics, Immunocompromised Patients, and Persons with History of Allergy or Prior SARS-CoV-2 Infection: Overview of Current Recommendations and Pre- and Post-Marketing Evidence for Vaccine Efficacy and Safety

C. Chiamulera, G. Trifirò, F. Pappalardo, 2021, Drug Safety.

Post-marketing active surveillance of Guillain Barré Syndrome following COVID-19 vaccination in persons aged ≥12 years in Italy: A multi-database self-controlled case series study

E. Bovo, C. Morciano, F. Menniti Ippolito, 2024, PloS one.

Post-marketing active surveillance of Guillan Barré Syndrome following vaccination with anti-COVID-19 vaccines in persons aged >=12 years in Italy: a multi-database self-controlled case series study

M. Massari, G. Trifirò, A. Puccini, 2023, medRxiv.

Safety profile assessment of HPV4 and HPV9 vaccines through the passive surveillance system of the Veneto Region (Italy) between 2008 and 2022: A 15-year retrospective observational study

R. Benoni, Filippo Da Re, M. Tonon, 2024, Vaccine: X.